Cytyc Corporation Chairman and CEO Scheduled to Present at SG Cowen & Co. Health Care Conference
Posted on: Thursday, 10 March 2005, 15:00 CST
Cytyc Corporation (Nasdaq: CYTC) today announced that Patrick J. Sullivan, chairman, president, and chief executive officer, is scheduled to present at the SG Cowen & Co. Health Care Conference on March 15, 2005, at 10:30 a.m. (Eastern), at the Boston Marriott Copley Place Hotel.
A live webcast and recording of the presentation will be available on Cytyc's website, http://ir.cytyc.com. The replay will be available approximately one hour after the presentation until March 28.
Cytyc Corporation is a leading women's health company that designs, develops, manufactures, and markets innovative and clinically effective products. Cytyc products cover a range of women's health applications, including cervical cancer screening, breast cancer risk assessment, treatment of excessive menstrual bleeding, and treatment of breast cancer. The ThinPrep(R) System is the most widely used method for cervical cancer screening in the United States. The ThinPrep System consists of the ThinPrep(R) 2000 Processor, ThinPrep(R) 3000 Processor, ThinPrep(R) Imaging System, and related reagents, filters, and other supplies. The ThinPrep System also provides the platform from which the Company launched its expansion into breast cancer risk assessment with the FirstCyte(R) Breast Test. The Cytyc Surgical Products Division manufactures and markets the NovaSure(R) Impedance Controlled Endometrial Ablation System, an innovative endometrial ablation device to treat menorrhagia, or excessive menstrual bleeding, and the MammoSite(R) Radiation Therapy System, a single-use device for the treatment of breast cancer.
Cytyc is traded on The Nasdaq Stock Market under the symbol CYTC. Cytyc, ThinPrep, FirstCyte, and NovaSure are registered trademarks of Cytyc Corporation.
Source: Business Wire
Related Articles
- Resolution Health Taps Health Care Economist Susheel Jain As VP, Corporate and Product Strategy
- NCCN Updates Cancer- and Treatment-Related Anemia Guidelines
- Specialized Health Products Enters Agreement With B.Braun Medical S.A.S. For International Distribution of SafeStep(R) Huber Needle Set
- St. Louis Cancer and Breast Institute to Get New AccuBoost System for Breast Cancer
- New York Business Group on Health Convenes Conference On Integrating Data and Delivery of Health Programs; Trends in Health & Productivity Management Series Continues April 12th
- NCCN Updates Cancer- and Treatment-Related Anemia Guidelines
- Specialized Health Products Reports First Quarter Financial Results; Company Achieves First $2 Million Revenue Quarter; Manufactured Product Sales Increase 74% to $1.4 Million
- NCCN Announces Important Updates to Cancer- and Treatment-Related Anemia Guidelines
- Two New, Cancer-Fighting TeaForHealth Green Tea Products, Presentation of ''The Science of Tea As Medicine'' and Q&A on FDA Qualified Health Claim for Green Tea
- Strong Market for Traditional Health Products
 |
 |
User Comments (0)
RSS Feeds